| Purposeful Therapy Solutions | |
|
177 S Hidden Valley Rd, Grenada, MS 38901-8804 | |
| (662) 414-0247 | |
| Not Available |
| Full Name | Purposeful Therapy Solutions |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 177 S Hidden Valley Rd, Grenada, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396420774 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Purposeful Therapy Solutions 177 S Hidden Valley Rd, Grenada, MS 38901-8804 Ph: (662) 414-0247 | Purposeful Therapy Solutions 177 S Hidden Valley Rd, Grenada, MS 38901-8804 Ph: (662) 414-0247 |
News Archive
Today is the 69th birthday of water fluoridation – the top public health blunder of all time, reports the New York State Coalition Opposed to Fluoridation, Inc. (NYSCOF)
Breast augmentation with implants does not interfere with the ability to detect later breast cancers-in fact, cancers may be detected at a smaller size in breasts with implants, according to a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Meda Pharmaceuticals Inc. (Meda) today announced the commercial availability of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United States. EDLUAR is indicated for the short-term treatment of insomnia characterized by difficulties with falling asleep. EDLUAR is the first available under-the-tongue formulation of zolpidem tartrate, which is the most prescribed treatment for insomnia. Zolpidem tartrate is also the active ingredient in Ambien(R) oral tablets.
New research has found that drug-resistant strains of tuberculosis are just as likely to be transmitted between people as drug-sensitive TB, which could make drug-resistant forms of the disease "highly prevalent in the next few decades," the Australian Associated Press/Sydney Morning Herald reports (Rose, 8/11).
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the FDA has granted Breakthrough Therapy designation to volasertib, an investigational inhibitor of polo-like kinase, being evaluated for the treatment of patients aged 65 or older with previously untreated acute myeloid leukemia, ineligible for intensive remission induction therapy.
› Verified 7 days ago
Mrs. Lauren Smith Sultan, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 965 Windsor Rd, Grenada, MS 38901 Phone: 662-809-1414 | |
Mrs. Kathy G Armstrong, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1300 Sunset Dr, Suite F, Grenada, MS 38901 Phone: 662-226-5747 Fax: 662-226-5622 | |
Courtney Rae Purvis, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 177 S Hidden Valley Rd, Grenada, MS 38901 Phone: 662-414-0247 | |
Laura Davis, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1966 Hill Dr, Grenada, MS 38901 Phone: 662-226-2442 Fax: 662-226-9567 | |
Candice Moore, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 105a Windmill Cv, Grenada, MS 38901 Phone: 662-299-6918 | |
Miss Tiffany Elmore, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 751 Choctaw St, Grenada, MS 38901 Phone: 601-201-8371 |